Table 3. Logistic regression analyses of risk factors for serosal invasion, node-positive and late stage patients in gastric cancer, respectively.
Characteristics | Serosal invasion | LN metastasis | TNM stage | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
RR | 95% CI | P | RR | 95% CI | P | RR | 95% CI | P | |||
Age (<60 vs. ≥60 years) | 0.458 | 0.266 to 0.789 | 0.005 | 0.925 | 0.526 to 1.627 | NS | 0.557 | 0.276 to 1.123 | NS | ||
Location (U/W vs. M/L) | 1.841 | 0.876 to 3.871 | NS | 0.620 | 0.308 to 1.247 | NS | 1.972 | 0.723 to 5.380 | NS | ||
Tumor size (>3 vs. ≤3 cm) | 9.718 | 5.428 to 17.396 | 0.000 | 3.051 | 1.626 to 5.725 | 0.001 | 6.302 | 3.173 to 12.514 | 0.000 | ||
Differentiation (differentiated vs. undifferentiated) | 0.481 | 0.281 to 0.823 | 0.008 | 0.446 | 0.253 to 0.785 | 0.005 | 0.446 | 0.219 to 0.905 | 0.025 | ||
HDL-C (≥54.2 vs. <54.2 mg/dL) | 1.808 | 1.038 to 3.151 | 0.037 | 2.481 | 1.398 to 4.404 | 0.002 | 2.544 | 1.254 to 5.161 | 0.010 | ||
Serosal invasion (no vs. yes) | – | – | – | 0.194 | 0.107 to 0.352 | 0.000 | 0.203 | 0.132 to 0.313 | 0.000 | ||
LN metastasis (no vs. yes) | – | – | – | – | – | – | 0.203 | 0.132 to 0.313 | 0.000 |
U/W, upper/whole body; M/L, middle/lower body; RR, risk ratio; CI, confidence interval; NS, no significant.